EMA Application withdrawn: Ertapenem Hospira (ertapenem sodium) — Hospira UK Limited

View source ↗

Summary

EMA has withdrawn the application for Ertapenem Hospira (ertapenem sodium) by Hospira UK Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections

Drugs mentioned

• Ertapenem Hospira (ertapenem sodium)

Snippet

Status: Application withdrawn. Therapeutic area: Bacterial Infections. MAH: Hospira UK Limited. Decision date: 14/10/2016